[Clinico-hematological effect of spirobromin in chronic lympholeukemia amd malignant non-Hodgkin's lymphoma].
Polianskaia
A M
AM
Khrennikova
G Iu
GIu
Sevast'ianova
M G
MG
Naumova
G A
GA
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D003520:Cyclophosphamide / Q000008:administration & dosage; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008214:Lymphocytes / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009930:Organic Chemicals; D011239:Prednisolone / Q000008:administration & dosage; D012751:Sezary Syndrome / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D009930:Organic Chemicals; D014750:Vincristine; C038297:spirobramin; D003520:Cyclophosphamide; D011239:Prednisolone
Kliniko-gematologicheskiĭ éffekt spirobromina pri khronicheskom limfoleĭkoze i zlokachestvennykh nekhodzhkinskikh limfomakh.